Table 3 The immunostaining of IGF-1R, IGF-2R, ERα and ERβ in EAC, atypical hyperplasia, and control groups
groups | n | ERα | ERβ | IGF-1R | IGF-2R | ||||
|---|---|---|---|---|---|---|---|---|---|
Positive (%) | Strong positive(%) | Positive (%) | Strong positive(%) | Positive (%) | Strong positive(%) | Positive (%) | Strong positive(%) | ||
Control | 22 | 22(100) | 22(100) | 13(59.09) | 3(13.64) | 14(63.64) | 1(5.0) | 16(72.72) | 10(45.45) |
Atypical hyperplasia | 33 | 32(95.65) | 31(93.93) | 26(78.79) | 15(45.45) | 25(75.76) | 9(27.27) | 27(81.82) | 25(75.75) |
EAC | 80 | 59(73.75) | 10(12.5) | 78(97.5) | 75(93.75) | 72(90.0) | 32(40.0) | 15(18.75) | 10(12.50) |
x 2 | 18.961 | 92.295 | 23.444 | 62.864 | 8.953 | 10.421 | 47.424 | 43.807 | |
P value | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.011 | 0.005 | 0.0000 | 0.0000 | |